If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGrainger plc Regulatory News (GRI)

Share Price Information for Grainger plc (GRI)

Share Price is delayed by 15 minutes
Get Live Data
171.70    1.60 (0.94%)
Bid:
171.60
Ask:
171.90
Spread: 0.30 (0.175%)
Market Cap: £1.27b
GRI Live PriceLast checked at - London Stock Exchange

Intraday Grainger plc Share Chart

Initial Response to Preliminary Approach

1 Apr 2010 10:00

RNS Number : 6066J
Sovereign Reversions PLC
01 April 2010
 



FOR IMMEDIATE RELEASE

 

1 April 2010

 

SOVEREIGN REVERSIONS PLC

("Sovereign" or the "Group")

 

The Board of Sovereign notes the announcement by Grainger PLC ("Grainger") of 29 March 2010. The Board has carefully considered the offer of 185 pence per share, taken advice from its financial advisers and has concluded that it significantly undervalues the Group's business and prospects. The Board is now seeking to establish a dialogue with Grainger in order to share information with a view to establishing the maximum price that Grainger would offer. The Board is also reviewing other options to maximise value for Sovereign shareholders.

 

Further announcements will be made as appropriate, but shareholders are recommended not to take any action in the meanwhile.

 

Charles Stanley Securities, Nominated Adviser

Tel: 020 7149 6000

Dugald J. Carlean / Ben Johnston

Graeme Marshall, Chief Executive, Sovereign Reversions plc

Tel: 01234 356300

Mark Baker, Wriglesworth Consultancy

Tel: 07980 635243

 

Charles Stanley Securities is a trading division of Charles Stanley & Co Limited, which is authorised and regulated in the United Kingdom by the Financial Services Authority, is acting exclusively for Sovereign Reversions PLC and its Directors and no one else in connection with this matter and will not be responsible to anyone other than Sovereign Reversions PLC and its Directors for providing the protections afforded to clients of Charles Stanley Securities nor for providing advice in relation to this matter, the content of this announcement or any matter referred to herein.

 

Dealing Disclosure Requirements

 

Under the provisions of Rule 8.3 of the Code, if any person is, or becomes "interested" (directly or indirectly) in 1% or more of any class of "relevant securities" of Sovereign Reversions PLC, all "dealings" in any "relevant securities" of Sovereign Reversions PLC (including by means of an option in respect of, or a derivative references to, any such "relevant securities") must be publicly disclosed by no later than 3.30pm (London time) on the London business day following the date of the relevant transaction. This requirement will continue until the date on which the offer becomes, or is declared, unconditional as to acceptances, lapses or is otherwise withdrawn or on which the "offer period" otherwise ends. If two or more persons act together pursuant to an agreement or understanding, whether formal or informal, to acquire an "interest" in "relevant securities" of Sovereign Reversions PLC they will be deemed to a single person for the purpose of Rule 8.3.

 

Under the provisions of Rule 8.1 of the Code, all "dealings" in "relevant securities" of Sovereign Reversions PLC by the potential offeror or Sovereign Reversions PLC or by any of their respective "associates", must be disclosed by no later than 12.00 noon (London time) on the business day following the date of the relevant transaction.

 

A disclosure table, giving details of the companies in whose "relevant securities" "dealings" should be disclosed, and the number of such securities in issue, can be found on the Takeover Panel's website at www.takeoverpanel.org.uk.

 

"Interests in securities" arise, in summary, when a person has long economic exposure, whether conditional or absolute to changes in the price of securities. In particular, a person will be treated as having an "interest" by virtue of the ownership or control of securities, or by virtue of any option in respect of, or derivative referenced to, securities. Terms in quotation marks are defined in the Code, which can also be found on the Takeover Panel's website. If you are in any doubt as to whether or not you are required to disclose a "dealing" under Rule 8, you should consult the Takeover Panel.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
OUPIBMPTMBIMMJM
Date   Source Headline
6th Apr 20232:02 pmRNSDirector/PDMR Shareholding
4th Apr 202310:25 amRNSBlock listing Interim Review
3rd Apr 20237:00 amRNSNotice of Results
13th Mar 202311:57 amRNSTotal Voting Rights
7th Mar 202312:46 pmRNSDirector/PDMR Shareholding
15th Feb 20231:35 pmRNSDirector/PDMR Shareholding
8th Feb 20234:16 pmRNSResult of AGM
8th Feb 20237:00 amRNSTrading Update
7th Feb 202312:12 pmRNSDirector/PDMR Shareholding
7th Feb 202312:08 pmRNSDirector/PDMR Shareholding
6th Feb 20233:14 pmRNSTotal Voting Rights
20th Jan 20235:12 pmRNSAGM Statement
12th Jan 202312:16 pmRNSTotal Voting Rights
10th Jan 20232:33 pmRNSDirector/PDMR Shareholding
13th Dec 20221:49 pmRNSDirector/PDMR Shareholding
13th Dec 20221:46 pmRNSDirector/PDMR Shareholding
8th Dec 202210:36 amRNSDirectorate Change
7th Dec 20221:33 pmRNSDirector/PDMR Shareholding
6th Dec 202211:47 amRNSTotal Voting Rights
21st Nov 20221:12 pmRNSDividend Declaration
17th Nov 20227:00 amRNSFinal Results
14th Nov 20227:00 amRNSBoard Appointment
7th Nov 20222:47 pmRNSDirector/PDMR Shareholding
11th Oct 20223:00 pmRNSDirector/PDMR Shareholding
6th Oct 20223:12 pmRNSBlock listing Interim Review
29th Sep 20223:20 pmRNSDirector/PDMR Shareholding
29th Sep 202211:08 amRNSTotal Voting Rights
20th Sep 20221:23 pmRNSDirector Declaration
12th Sep 20227:00 amRNSTRADING UPDATE
12th Sep 20227:00 amRNSTrading Update
7th Sep 20222:31 pmRNSTotal Voting Rights
6th Sep 202212:29 pmRNSDirector/PDMR Shareholding
17th Aug 20222:49 pmRNSHolding(s) in Company
8th Aug 20222:34 pmRNSDirector/PDMR Shareholding
5th Jul 20227:00 amRNSDirector/PDMR Shareholding
5th Jul 20227:00 amRNSCapital Markets Event
4th Jul 20223:33 pmRNSHolding(s) in Company
23rd Jun 20227:00 amRNSAcquisition
14th Jun 20222:22 pmRNSAdditional Listing
8th Jun 20223:06 pmRNSDirector/PDMR Shareholding
25th May 202210:00 amRNSHolding(s) in Company
12th May 20227:00 amRNSHalf Year Financial Results
6th May 202210:48 amRNSDirector/PDMR Shareholding
21st Apr 20222:15 pmRNSHolding(s) in Company
7th Apr 202212:01 pmRNSDirector/PDMR Shareholding
1st Apr 202212:08 pmRNSBlock listing Interim Review
25th Mar 20227:00 amRNSNotice of Interim Results
7th Mar 202212:05 pmRNSDirector/PDMR Shareholding
3rd Mar 202212:12 pmRNSTotal Voting Rights
3rd Mar 202212:08 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.